Journal Article Review Epublish 26 citations
PubMed: 32751826 DOI: 10.3390/ijms21155471
Approaches and Technologies in Male Fertility Preservation.
Int J Mol Sci 21(15)
Authors: Mahmoud Huleihel, Eitan Lunenfeld
Affiliations
- The Shraga Segal Department of Microbiology, Immunology, and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel.
- The Center of Advanced Research and Education in Reproduction (CARER), Ben-Gurion University of the Negev, Beer Sheva 84105, Israel.
- Department of OB/GYN, Soroka Medical Center, Beer Sheva 8410501, Israel.
- Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel.
Abstract
Male fertility preservation is required when treatment with an aggressive chemo-/-radiotherapy, which may lead to irreversible sterility. Due to new and efficient protocols of cancer treatments, surviving rates are more than 80%. Thus, these patients are looking forward to family life and fathering their own biological children after treatments. Whereas adult men can cryopreserve their sperm for future use in assistance reproductive technologies (ART), this is not an option in prepubertal boys who cannot produce sperm at this age. In this review, we summarize the different technologies for male fertility preservation with emphasize on prepubertal, which have already been examined and/or demonstrated in vivo and/or in vitro using animal models and, in some cases, using human tissues. We discuss the limitation of these technologies for use in human fertility preservation. This update review can assist physicians and patients who are scheduled for aggressive chemo-/radiotherapy, specifically prepubertal males and their parents who need to know about the risks of the treatment on their future fertility and the possible present option of fertility preservation.
MeSH
Radiotherapy, Fertility, Fertility Preservation, Drug Therapy, Therapeutics, Infertility, Male, Spermatogenesis, Spermatozoa, Testis, Chemotherapy
Cited by
- Coping with Oxidative Stress in Reproductive Pathophysiology and Assisted Reproduction: Melatonin as an Emerging Therapeutical Tool. Antioxidants (Basel), 2023
- Effect of Temperature on the Development of Stages of Spermatogenesis and the Functionality of Sertoli Cells In Vitro. Int J Mol Sci, 2024
- Fertility preservation in men with hypogonadotropic hypogonadism secondary to germinoma: two cases of gonadotropin replacement therapy before induction of anticancer chemotherapy. Int Cancer Conf J, 2024
- Trans-epithelial/endothelial electrical resistance (TEER): Current state of integrated TEER measurements in organ-on-a-chip devices. Curr Opin Biomed Eng, 2025
- Immature rat testis sustained long-term development using an integrative model. Biol Res, 2022
- Sperm Selection Procedures for Optimizing the Outcome of ICSI in Patients with NOA. J Clin Med, 2021
- Perfusion in Organ-on-Chip Models and Its Applicability to the Replication of Spermatogenesis In Vitro. Int J Mol Sci, 2022
- In Vitro Culture of Vitrified Immature Mouse Testicular Tissue in The Presence of N-acetylcysteine Antioxidant. Int J Fertil Steril, 2025
- Biomaterials for Testicular Bioengineering: How far have we come and where do we have to go? Front Endocrinol (Lausanne), 2023
- Testicular sperm extraction (TESE) outcomes in the context of malignant disease: a systematic review. Asian J Androl, 2022